Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma

Gurnell, M, Domingo, C, Rabe, K F, Menzies-Gow, A, Price, D, Brusselle, G, Wechsler, M E, Xia, C, Pandit-Abid, N, Gall, R, Jacob-Nara, J A, Rowe, P J, Deniz, Y & Siddiqui, S 2022, 'Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma', European Respiratory Journal, vol. 60, no. Suppl. 66, 3620. https://doi.org/10.1183/13993003.congress-2022.3620